Literature DB >> 21421582

In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus.

Pavel Novy1, Jan Urban, Olga Leuner, Jaroslav Vadlejch, Ladislav Kokoska.   

Abstract

OBJECTIVES: In this study we examined the in vitro synergistic effect of baicalin, the flavone constituent of Scutellaria spp., in combinations with oxytetracycline and tetracycline on the growth of Staphylococcus aureus.
METHODS: The MICs were determined by the broth microdilution method and the effect of combinations was evaluated according to the sum of fractional inhibitory concentration indices (FICIs).
RESULTS: Synergistic activity (FICI  ≤  0.5) was observed for combinations of baicalin with oxytetracycline or tetracycline against 4 of 10 strains tested, whereas the baicalin/oxytetracycline combination possessed the strongest synergistic effect (FICI = 0.418).
CONCLUSIONS: Baicalin acts synergistically with oxytetracycline and tetracycline, enhancing its antimicrobial activity against S. aureus, including methicillin- and tetracycline-resistant strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421582     DOI: 10.1093/jac/dkr108

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

Review 1.  Effects of Traditional Chinese Medicine and its Active Ingredients on Drug-Resistant Bacteria.

Authors:  Jimin Li; Shanshan Feng; Xin Liu; Xu Jia; Fengling Qiao; Jinlin Guo; Shanshan Deng
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis.

Authors:  Jiali Zhu; Jiafeng Wang; Ying Sheng; Yun Zou; Lulong Bo; Fei Wang; Jingsheng Lou; Xiaohua Fan; Rui Bao; Youping Wu; Feng Chen; Xiaoming Deng; Jinbao Li
Journal:  PLoS One       Date:  2012-05-08       Impact factor: 3.240

3.  Effects of Luteolin and Quercetin in Combination with Some Conventional Antibiotics against Methicillin-Resistant Staphylococcus aureus.

Authors:  Muhammad Usman Amin; Muhammad Khurram; Taj Ali Khan; Hani S Faidah; Zia Ullah Shah; Shafiq Ur Rahman; Abdul Haseeb; Muhammad Ilyas; Naseem Ullah; Sahibzada Muhammad Umar Khayam; Marcello Iriti
Journal:  Int J Mol Sci       Date:  2016-11-22       Impact factor: 5.923

4.  Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.

Authors:  Jing Luo; Biying Dong; Ke Wang; Shuangqi Cai; Tangjuan Liu; Xiaojing Cheng; Danqing Lei; Yanling Chen; Yanan Li; Jinliang Kong; Yiqiang Chen
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

5.  Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.

Authors:  Li Lu; Li Rao; Huanhuan Jia; Jun Chen; Xingyan Lu; Guozhu Yang; Qingnan Li; Kenneth Ka Ho Lee; Li Yang
Journal:  J Cell Mol Med       Date:  2017-02-03       Impact factor: 5.310

6.  In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.

Authors:  Weifeng Yang; Jueling Liu; Biljana Blažeković; Yanan Sun; Shuhua Ma; Chuanyun Ren; Sanda Vladimir-Knežević; Chaohua Li; Yajun Xing; Guijie Tian; Yi Wang
Journal:  BMC Complement Altern Med       Date:  2018-05-30       Impact factor: 3.659

7.  Baicalin serves a protective role in diabetic nephropathy through preventing high glucose-induced podocyte apoptosis.

Authors:  Jindong Li; Ya Ling; Shengnan Yin; Shufang Yang; Min Kong; Zhiqin Li
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

8.  Theaflavin-3,3´-digallate increases the antibacterial activity of β-lactam antibiotics by inhibiting metallo-β-lactamase activity.

Authors:  Zihao Teng; Yan Guo; Xingqi Liu; Jian Zhang; Xiaodi Niu; Qinlei Yu; Xuming Deng; Jianfeng Wang
Journal:  J Cell Mol Med       Date:  2019-08-08       Impact factor: 5.310

9.  Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin.

Authors:  Huiyi Wu; Xiaoying Long; Fei Yuan; Li Chen; Sujing Pan; Yunjun Liu; Yoshiko Stowell; Xiaoling Li
Journal:  Acta Pharm Sin B       Date:  2014-04-29       Impact factor: 11.413

10.  Mechanisms of action and in vivo antibacterial efficacy assessment of five novel hybrid peptides derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.

Authors:  Hassan Mahmood Jindal; Keivan Zandi; Kien Chai Ong; Rukumani Devi Velayuthan; Sara Maisha Rasid; Chandramathi Samudi Raju; Shamala Devi Sekaran
Journal:  PeerJ       Date:  2017-10-05       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.